Pharma ’s Nutritional Value

With previous senior management roles at both Novartis and Boehringer Ingelheim, Greg Behar is a pharma man – or he was. In 2014, he became CEO ofNestl é Health Science, a company whose mission is to place nutrition into a key role in the management of people ’s health.While Nestl é itself is best-known as a manufacturer of confectionary, Nestlé Health Science occupies the space between nutrition and pharma – science-based, personalized nutritional therapies. Behar, who will be speaking ateyeforpharma Barcelona 2017, says the company offers great opportunities to develop “amazing breakthrough approaches to treatment”.“The first thing I explain to former colleagues is that, in pharma, working on a first-in-class product is perhaps a once-in-a-lifetime opportunity,” he says. “But more than 75% of our pipeline portfolio at Nestlé is first-in-class.”A new health frontierThemicrobiome space alone is one of the most exciting health developments since biologics, he says, offering the potential to change the management of a wide range of health conditions.Right now, it ’s not a priority for pharma. They see this more as a complicating factor in their development path, but as we start to show more success, there will be more people coming in.Yet, given pharma ’s increasing chatter aroundpatient centricity, it is surprising that pharma is not currently beating down Nestl é Health Science’s door for partnership and collaboration opportunities.“Right now, i...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news